Education
About Us
Working with TipRanks
Follow Us
Wuxi Biologics (Cayman) (HK:2269)
:2269
2269 Analyst Ratings
Moderate Buy
2 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
2269 Stock 12 Month Forecast
Average Price Target
HK$28.57
▼(-4.28%Downside)
| Highest Price TargetHK$34.22 | Average Price TargetHK$28.57 | Lowest Price TargetHK$23.39 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
HK$32
Buy
7.20%
Upside
Reiterated
07/19/25
Wuxi Biologics achieves a solid overall score driven by strong financial performance and positive technical indicators. However, the relatively high P/E ratio suggests the stock may be overvalued, requiring continued strong earnings growth to sustain its price. The absence of earnings call analysis and corporate events does not affect the score significantly.
Nomura
HK$34.36→HK$34.23
Buy
14.67%
Upside
Reiterated
07/16/25
DBS
HK$24→HK$23.4
Hold
-21.61%
Downside
Reiterated
07/02/25
J.P. Morgan
HK$32→HK$28
Buy
-6.20%
Downside
Reiterated
05/06/25
Jefferies
HK$45
Buy
50.75%
Upside
Reiterated
03/31/25
Citi
HK$30→HK$35
Buy
17.25%
Upside
Reiterated
03/31/25
CMB International Securities
HK$24.24→HK$30.94
Buy
3.65%
Upside
Reiterated
03/27/25
CLSA
HK$26→HK$28.8
Buy
-3.52%
Downside
Reiterated
03/27/25
Goldman Sachs
HK$20.8→HK$23.4
Hold
-21.61%
Downside
Reiterated
03/27/25
Unknown AnalystUOB Kay Hian
Not Ranked
UOB Kay Hian
HK$35
Buy
17.25%
Upside
Reiterated
03/27/25
Macquarie
HK$27
Hold
-9.55%
Downside
Reiterated
03/26/25
Morgan Stanley
HK$32
Buy
7.20%
Upside
Reiterated
08/30/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
HK$32
Buy
7.20%
Upside
Reiterated
07/19/25
Wuxi Biologics achieves a solid overall score driven by strong financial performance and positive technical indicators. However, the relatively high P/E ratio suggests the stock may be overvalued, requiring continued strong earnings growth to sustain its price. The absence of earnings call analysis and corporate events does not affect the score significantly.
Nomura
HK$34.36→HK$34.23
Buy
14.67%
Upside
Reiterated
07/16/25
DBS
HK$24→HK$23.4
Hold
-21.61%
Downside
Reiterated
07/02/25
J.P. Morgan
HK$32→HK$28
Buy
-6.20%
Downside
Reiterated
05/06/25
Jefferies
HK$45
Buy
50.75%
Upside
Reiterated
03/31/25
Citi
HK$30→HK$35
Buy
17.25%
Upside
Reiterated
03/31/25
CMB International Securities
HK$24.24→HK$30.94
Buy
3.65%
Upside
Reiterated
03/27/25
CLSA
HK$26→HK$28.8
Buy
-3.52%
Downside
Reiterated
03/27/25
Goldman Sachs
HK$20.8→HK$23.4
Hold
-21.61%
Downside
Reiterated
03/27/25
Unknown AnalystUOB Kay Hian
Not Ranked
UOB Kay Hian
HK$35
Buy
17.25%
Upside
Reiterated
03/27/25
Macquarie
HK$27
Hold
-9.55%
Downside
Reiterated
03/26/25
Morgan Stanley
HK$32
Buy
7.20%
Upside
Reiterated
08/30/24
Best Analysts Covering Wuxi Biologics (Cayman)
1 Month
xxx
Success Rate
4/7 ratings generated profit
Average Return
+3.56%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +3.56% per trade.
3 Months
xxx
Success Rate
5/7 ratings generated profit
Average Return
+7.79%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +7.79% per trade.
1 Year
Success Rate
6/7 ratings generated profit
Average Return
+52.70%
reiterated a buy rating 10 days ago
Copying Jialin Zhang's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +52.70% per trade.
2 Years
xxx
Success Rate
6/7 ratings generated profit
Average Return
+57.47%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +57.47% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
2269 Analyst Recommendation Trends
Rating
Jan 25
Feb 25
Mar 25
May 25
Jul 25
Strong Buy
3
5
12
12
11
Buy
0
0
0
0
0
Hold
2
2
3
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
7
15
15
14
Each month's total comprises the sum of three months' worth of ratings.
2269 Financial Forecast
2269 Stock Forecast FAQ
What is HK:2269’s average 12-month price target, according to analysts?
Based on analyst ratings, Wuxi Biologics (Cayman) ’s 12-month average price target is 28.57.
What is HK:2269’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:2269, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Wuxi Biologics (Cayman) a Buy, Sell or Hold?
Wuxi Biologics (Cayman) has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.
What is Wuxi Biologics (Cayman) ’s share price target?
The average share price target for Wuxi Biologics (Cayman) is 28.57. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$34.22 ,and the lowest forecast is HK$23.39. The average share price target represents -4.28% Decrease from the current price of HK$29.85.
The highest analyst share price target is HK$34.22 ,and the lowest forecast is HK$23.39. The average share price target represents -4.28% Decrease from the current price of HK$29.85.
What do analysts say about Wuxi Biologics (Cayman) ?
Wuxi Biologics (Cayman) ’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of Wuxi Biologics (Cayman) ?
To buy shares of HK:2269, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.